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SEROPREVALENCE FOR HEPATITIS E VIRUS (HEV) INFECTION AMONG VOLUNTEER BLOOD
DONORS OF THE REGIONAL BLOOD BANK OF LONDRINA, STATE OF PARANÁ, BRAZIL
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SUMMARY
A cross-sectional study was carried out among 996 volunteer blood donors enrolled from May 1999 to December 1999 to
determine the seroprevalence of hepatitis E virus (HEV) infection among volunteer blood donors of the Regional Blood Bank of
Londrina, State of Paraná, Brazil, and to evaluate whether the rate of seroprevalence of IgG anti-HEV antibodies is associated with
sociodemographic variables and with seropositivity for hepatitis A virus (HAV) infection. All participants answered the questionnaire
regarding the sociodemographic characterisitcs. Serum samples were tested for IgG antibodies to HEV (anti-HEV) by an enzyme
linked immunoassay (ELISA). All serum samples positive for anti-HEV IgG and 237 serum samples negative for anti-HEV were
also assayed for IgG anti-HAV antibodies by ELISA. Anti-HEV IgG was confirmed in 23/996 samples, resulting in a seroprevalence
of 2.3% for HEV infection, similar to previous results obtained in developed countries. No significant association was found
between the presence of anti-HEV IgG antibodies and the sociodemographic variables including gender, age, educational level,
rural or urban areas, source of water, and sewer system (p > 0.05). Also, no association with seropositivity for anti-HAV IgG
antibodies was observed (p > 0.05). Although this study revealed a low seroprevalence of HEV infection in the population evaluated,
the results showed that this virus is circulating among the population from Londrina, South Brazil, and point out the need of
further studies to define the clinical and epidemiological importance of HEV infection and to identify additional risk factors
involved in the epidemiology and pathogenesis of this infection in this population.
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INTRODUCTION
Epidemic jaundice has been recognized from the time of
Hippocrates over 2000 years ago. However, it was only between 1965
and 1990 that the various human hepatitis viruses, their syndromes
and their role in hepatic oncogenesis were determined, leading to the
expansion of their nomenclature from A to E. It has been estimated
that between four and 19% of patients with sporadic, community-
acquired acute hepatitis have no detectable viral agent22.
Hepatitis E virus (HEV) is considered a major etiological agent of
enterically transmitted viral hepatitis in several developing countries25.
The infection has been shown to occur in both epidemic and sporadic
forms and to be primarily associated with ingestion of fecally
contamined drinking water31.
HEV infection is quite common in some world areas such as India,
Africa and Southeast Asia, where it can represent the main cause of
acute hepatitis27. In India, this infection is the main cause of sporadic
cases of non-A, non-B and non-C hepatitis18. Outbreaks of HEV
infection have been reported from Central Asia, Southeast Asia, the
Middle East, Northern Africa, Sub-Saharan Africa, and Mexico31. In
the Xinjiang area of China, 119,280 cases of HEV infection were
notified in the epidemic of 1986 to 198819.
In addition, epidemiological investigation in non-endemic areas
has shown a low, but constant presence of anti-HEV antibodies (about
1.2%) in normal human populations27,31. In Brazil, outbreaks of hepatitis
E have never been reported, although some authors have demonstrated
the evidence of anti-HEV antibodies in some population groups12,24,27,31.
The seroprevalence of anti-HEV IgG among normal Brazilian
populations was reviewed8 and reported a positivity of 6.1% among
gold miners, 3.3% in the general population, 2.0-7.5% among blood
donors, 1.0% among pregnant women, and 4.5% in children, with no
difference among regions. The review also showed that the prevalence
of anti-HEV varies widely in populations considered to be at risk.
Among patients with acute non-A, non-B, non-C hepatitis, the
prevalence was 2.1% in the Southeast, 29% in the Northeast, 10.6%
among relative of acute non-A, non-B, non-C hepatitis patients in the
Amazon basin, 12% among acute sporadic non-A non-B hepatitis
patients in the Northeast, 25 to 38% among patients co-infected with
acute hepatitis A in the Northeast, 14 to 18% among prostitutes and
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women considered at risk for human immunodeficiency virus type 1
(HIV-1) in the Southeast, and 12% among intravenous drug users in
the Southeast8. In the State of Paraná, South Brazil, no studies of the
HEV infection have been reported.
HEV infection usually presents an acute and benign clinical course
and does not provoke chronic infection. However, among all the
responsible hepatitis viruses, HEV is associated with the largest number
of fulminant hepatitis cases (3.0%) in the general population, and up
to 20% in pregnant women7.
Hepatitis A virus (HAV) is an extremely stable virus which is spread
by the fecal-oral route, either directly from person to person or by
contamined food or water, with the prevalence being closely correlated
with the degree of environmental sanitation and the prevailing
socioeconomic and hygienic conditions33. Considering that the HEV
and HAV infections share the same transmission routes, it is possible
that the local seroprevalence of both infections may also be similar.
However, few studies have examined the epidemiology of the
association between HEV and HAV infections.
The aim of this study was to determine the seroprevalence of HEV
infection among volunteer blood donors of the Regional Blood Bank
of Londrina, State of Paraná, Brazil, and to evaluate whether the rate
of seroprevalence of anti-HEV IgG antibodies is associated with the
sociodemographic characterisitcs and the seropositivity for HAV
infection. These data can contribute to define the epidemiological
importance of the HEV infection in this district and to elaborate rational
clinical and epidemiological strategies in the investigation of cases
classified as non-A, non-B, and non-C hepatitis.
MATERIALS AND METHODS
A cross-sectional study was carried out to determine the
seroprevalence of HEV infection among volunteer blood donors of the
Blood Bank of the Universitary Hospital, Londrina, State of Paraná,
South Brazil. The protocol was approved by the institutional Research
Ethics Committee of Londrina State University. The individuals were
invited to participate and informed in detail about the research, and
voluntary written consent was obtained from the subjects enrolled.
Study population: The convenience sample consisted of individuals
consecutively recruited during the period from May 1999 to December
1999. For the population of 250,000 adults aged 18 to 60 years living
in district of Londrina, with an estimated prevalence of seropositivity
for HEV infection of 0.025 (with an error margin of 0.01), the calculated
sample size was of 933 individuals, with a confidence interval (CI) of
95%. In order to decrease the margin of error, 996 blood donors were
evaluated. A questionnaire was applied to the participants to obtain
information about sociodemographic data including gender, age,
educational level, place of residence (rural or urban area), source of
water, and the sanitary conditions of their homes (sewer or pit), in
order to evaluate possible risk factors for HEV infection. On the basis
of the standard clinical screening of the blood donors, all individuals
enrolled in this study were also questioned about a past clinical history
of symptomatic hepatitis.
The results obtained for the blood donors with positive anti-HEV
IgG were compared with those obtained for blood donors with negative
anti-HEV IgG.
Serological assays for anti-HEV IgG and anti-HAV IgG: All serum
samples were stored at -20 oC until used. Serum samples were tested
for specific anti-HEV IgG antibodies by enzyme linked immunosorbent
assay (ELISA), according to the method described elsewhere32 using
commercially available reagents (HEV EIA, ABBOTT Laboratories,
IL, USA). According to the manufacturer, this assay presents 98.5%
sensitivity and 99.5% specificity. The results were scored as positive
or negative according to standard procedures recommended by the
manufacturers. The individuals were considered to be seropositive when
they showed two repeated positive reactions. Positive and negative
controls were included in all the ELISA microplates assayed. All serum
samples from blood donors positive for anti-HEV IgG and 237 samples
from blood donors negative for anti-HEV IgG were also assayed for
anti-HAV IgG antibodies by ELISA, as described elsewhere11, using
commercially available products (ABBOTT Laboratories, HAV EIA).
According to the manufacturer, the assay presents 99.0% sensitivity
and 99.5% specificity.
Statistical analysis: A database was set up using the EPI INFO
software version 6.04d10. Descriptive statistical analysis was used to
calculate the mean, median, standard deviation (SD), and percentage
of the sociodemographic variables of the blood donors, and 95%
confidence intervals (95% CI) of the proportion of seropositivity for
anti-HEV IgG and anti-HAV IgG antibodies and the variables evaluated.
The statistical analysis was performed using the Chi-square (x2) and
Exact Fisher tests. The level of significance adopted for all tests was
5% (p < 0.05).
RESULTS
The age of the volunteer blood donors ranged from 18 to 60 years
(mean: 29.9 ± 9.8 years; median: 26.9 years) and 605 (60.7%) were
males. Table 1 shows that 23 blood donors showed positive anti-HEV
IgG antibodies, corresponding to an overall seroprevalence rate of 2.3%
(95% CI = 1.5 - 3.5). The sociodemographic characteristics of the
blood donors enrolled according to seropositivity for anti-HEV IgG
are shown in Table 2. No association was observed (p > 0.05) between
seropositivity and the variables evaluated including gender, age (≤ 35
years old and > 35 years old), educational level (incomplete elementary
school and ≥ elementary school), origin (urban or rural area), source
of water (public or other) and sewer (public service or pit). Most subjects
lived under adequate sanitary housing conditions in view of the high
Table 1
Distribution of the results of anti-hepatitis virus E antibodies (anti-HEV) IgG in
serum samples from volunteer blood donors of the Regional Blood Bank of
Londrina, Paraná, Brazil
ANTI-HEV IgG * Number % CI† (95%)
Positive 23 2.3 1.5 – 3.5
Negative 973 97.7 96.5 – 98.5
Total 996 100.0
* Anti-hepatitis virus E IgG antibodies evaluated by enzyme immunoassay
(ELISA); †: confidence interval.
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rate of presence of a sewage system (73.2%) and public water (98.6%).
All the 23 (100.0%) subjects with positive results for anti-HEV IgG
and 959 (98.6%) with negative results had public piped water available.
Therefore, there was no statistically significant difference in anti-HEV
prevalence when the presence of a sewage system and the source of
water were taken into consideration.
The results obtained from the 23 blood donors with positive anti-
HEV IgG were compared with those obtained from 237 blood donors
with negative anti-HEV IgG. Among the 260 serum samples assayed
for anti-HAV IgG, 211 were positive for anti-HAV IgG, corresponding
to a seropositivity of 81.1%. Among the positive samples for anti-
HEV IgG, 19 (82.6%) were also positive for anti-HAV IgG. Regarding
the samples that were negative for anti-HEV IgG, 192 (81.0%) were
also positive for anti-HEV IgG. No association between the two rates
of seropositivity (anti-HEV and anti- HAV) was observed (p = 1,000),
as shown in Table 3.
DISCUSSION
Viral hepatitis is considered to be a worldwide public health
problem, representing a significant cause of morbidity and mortality.
On most occasions, the etiologic agent of the infection is not defined,
generating problems in the handling of those cases and in the decision
about the most adequate prophylactic measures.
The areas of the world with a high incidence of HEV infection are
mainly developing countries, mainly in Asia and in Africa. In Brazil,
different patterns of hepatitis virus distribution are found throughout
the country. Outbreaks of HEV infection have not yet been described.
However, the possibility of the occurrence of such outbreaks exists
since in our country there are great social differences and sanitary
conditions are quite precarious in many areas. Besides, the disease
surveillance is deficient in the country as a whole, with the consequent
serious problem of undernotification of cases.
Table 3
Seropositivity for anti-hepatitis A virus (anti-HAV) IgG antibodies obtained for volunteer blood donors of the Regional Blood Center of Londrina, Paraná, Brazil,
distributed according to the seropositivity for anti-hepatitis E virus (anti-HEV) IgG antibodies
Serologic result Anti-HEV*Positive  n (%) Anti-HEV*Negative n (%) Total n (%) CI‡ (95%)
Anti-HAV† positive  19 (82.6)  192 (81.0)  211 (81.1) 75.75-85.61
Anti-HAV† negative  4 (17.4)  45 (19.0)  49 (18.8) 14.39-24.25
Total  23 (100.0)  237 (100.0)  260 (100.0)
*: Anti-hepatitis E virus IgG antibodies evaluated by enzyme immunoassay (ELISA); †: Anti-hepatitis A virus IgG antibodies evaluated by enzyme immunoassay
(ELISA); Exact Fisher Test: p = 1.000 (not significant); ‡CI: confidence interval.
Table 2
Sociodemographic characteristics of 996 volunteer blood donors of the Regional Blood Bank of Londrina, Paraná, Brazil, distributed according to seropositivity for
anti-hepatitis virus E (anti-HEV IgG) antibodies
Characteristic Anti-HEV positive Anti-HEV negative Total p value
n (%) n (%) n (%)
Gender
Male 15 (65.2) 590 (60.6) 605 (60.7) 0.8190* NS
Female 08 (34.8) 383 (39.4) 391 (39.3)
Age (years)
≤ 35 17 (73.9) 692 (71.1) 709 (71.2) 0.9526* NS
> 35 06 (26.1) 281 (28.9) 287 (28.8)
Place of residence
Rural area 02 (8.7) 058 (6.0) 060 (6.0) 0.6442† NS
Urban area 21 (91.3) 915 (94.0) 936 (94.0)
Education
Elementary school 05 (21.7) 175 (18.0) 180 (18.1) 0.5886† NS
≥ Elementary school 18 (78.3) 798 (82.0) 816 (81.9)
Source of water
Public 23 (100.0) 959 (98.6) 982 (98.6) 1.000† NS
Other (mine, shaft) 00 (0.0) 014 (1.4) 014 (1.4)
Sanitary conditions
Sewer 14 (60.9) 715 (73.5) 729 (73.2) 0.2660* NS
Pit (closed and open) 09 (39.1) 258 (26.5) 267 (26.8)
* Chi-square test (x2); † Exact Fisher Test; n: number of samples; NS: not significant.
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According to the Municipal Health System, in the district of
Londrina, State of Paraná, in the year of 1999, it was not possible to
identify the etiologic agent in 6% of the total of cases of viral hepatitis
and those cases were classified as non-A, non-B, and non-C hepatitis
infections (personal communication). On this basis, it is possible that
some of those cases might have been HEV infection.
The 2.3% seroprevalence of anti-HEV IgG obtained among
volunteer blood donors residing in the district of Londrina enrolled in
this study is similar to that reported in other recently reviewed Brazilian
studies8. In the city of São Paulo, State of São Paulo, a previous
investigation detected a seroprevalence of 1.68% for anti-HEV IgG
antibodies in the general population12. In another study carried out in
Campinas, State of São Paulo, the seroprevalence was 3.0% among
blood donors from that municipal district13. In Salvador (State of Bahia),
the seroprevalence of anti-HEV IgG antibodies among blood donors
was 2.0%24. In Rio de Janeiro (State of Rio de Janeiro), a retrospective
study conducted on selected populations revealed a 4.3% of prevalence
of anti-HEV IgG among the different groups and among blood donors31.
In a study carried out in riverine communities from the Western Region
of the Brazilian Amazon Basin, the overall prevalence observed (4.0%)
was considered to be low25.
As mentioned previously, the main route of transmission of HEV
infection is the fecal-oral one, which is also the route of transmission
of HAV infection, whose prevalence is associated with the quality of
the individuals’ life including housing, drinking water, and sewer
service5. HAV infection is highly prevalent in Brazil, as demonstrated
in a study carried out in the city of São Paulo, State of São Paulo, on
individuals ranging in age from 16 to 30 years, in which the prevalence
of anti-HAV was 91.9% among individuals of middle socioeconomic
condition and 100% among those of low socioeconomic condition23.
Regarding the similarity of the transmission mechanisms, there is
a trend to evaluate the association between these two infections (HAV
and HEV infections). A study carried out in Israel on hemophiliac
patients detected a strong association between the viruses6. In Brazil,
the same association was found in a study carried out in Salvador,
State of Bahia, and the authors concluded that similarities exist between
the epidemiology of the two infections, and that individuals exposed
to HAV have a higher probability to be also exposed to HEV24.
In the present study, no association was found between these two
infections, a result similar to that reported in a study that evaluated the
prevalence of these viruses in the general population of the city of São
Paulo, State of São Paulo12. Also, no association was found in the urban
population of Burundi, Africa, and the authors concluded that, although
the two viruses are transmitted by the fecal-oral route, the epidemic
models of the two infections are different3. HEV infection has a few
distinct epidemiological features that differentiate it from HAV
infection. Unlike HAV infection, HEV infection appears to affect mainly
young adults, which is unusual for a virus transmitted via the fecal-
oral route. Also unusual is that secondary cases of HEV infection are
much less frequent than HAV infection, and finally a major difference
is the high mortality rate observed among pregnant women infected
with HEV31.
In California (USA), a group of candidates to blood donors was
evaluated and the results did not show an association between those
infections and the authors concluded that, possibly, different patterns
of transmission of the two viruses may exist and the risk factors for
HEV infection in the sporadic cases that occur in non-endemic areas
have not been defined20.
Similarly, in this study, since the association of the type of water
consumed, including the use of untreated water, with the soroprevalence
of IgG anti-HEV antibodies was not demonstrated, other possible
transmission routes should be suggested.
HEV infection, unlike HAV infection, presents a very low rate of
inter-human transmission, as demonstrated by several authors 1,3,15,26,28,30.
According to these authors, this route of transmission of HEV infection
should not be the only one responsible for the sporadic cases that occur
in non-endemic areas. Other transmission mechanisms, not yet clarified,
may play an important role in the epidemiology of HEV infection in
these areas.
According to some authors, HEV infection could be classified as a
zoonosis because some animals may act as reservoirs of the virus, a
fact justifying the circulation of the virus in non-endemic areas4,9,14,16,17,26.
Occasionally, HEV may infect humans through direct contact with
domestic or farm animals or with contaminated water supplies25.
The analysis of the genome of the HEV isolated from swine and
from individuals with HEV infection suggests that these animals can
serve as a reservoir of the virus21. The existence of cross-infection
with HEV between humans and swine is a possibility that cannot be
ruled out36. The high prevalence of HEV antibodies among apparently
healthy humans (20.0%) and farm pigs (72.0%) in Bali, Indonesia,
whose population is mostly Hindu and has a habit of consuming pork,
indicates that HEV infection may occur as a zoonosis35.
In a study, related by authors as the first report that showed
evidences of HEV circulation in Brazilian animal species and pig
handlers, was detected the soroprevalences of HEV infection in cows
(1.42%), dogs (6.97%), chickens (20%), swines (24.3%) and rodents
(50.0%), as well in pig handlers (6.3%)34. The recognition of swine
HEV infection in pigs in many countries of the world led these authors
to investigate a larger sample of pigs of same Brazilian region that
demonstrated a total seroprevalence of 63.6%. However, as the
seroprevalence reached 97.3% of animals older than 25 weeks, the
authors concluded that swine HEV infection seems to be almost
universal within this Brazilian pig population34.
The true participation of the animals in the transmission of HEV is
still unclear, with many points that still require elucidation. Similarly,
the true meaning of the seroprevalence of the anti-HEV IgG antibodies
detected in the present study it is still to be defined.
Taken together, although showing a low prevalence of HEV
infection among blood donors, the results obtained in the present study
demonstrate that HEV circulates in the district of Londrina. However,
further studies are necessary to define the clinical and epidemiologic
importance of the HEV infection in this area and to identify additional
risk factors involved in the epidemiology and pathogenesis of HEV
infection. The results obtained open the possibility of other routes of
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spreading different from that previously recognized ones such as fecal-
oral contamination, mainly the possible participation of animals in the
transmission of HEV.
RESUMO
Soroprevalência da infecção pelo virus da hepatite E (VHE) em
candidatos a doadores de sangue voluntários do Hemocentro
Regional de Londrina, Londrina, Estado do Paraná, Brasil
Os objetivos do estudo foram determinar a soroprevalência da
infecção pelo vírus da hepatite E (VHE) em candidatos a doadores de
sangue voluntários do Hemocentro Regional de Londrina, Paraná, e
avaliar se essa soroprevalência está associada com variáveis socio-
demográficas e com o índice de soropositividade para hepatite por
vírus A (VHA). Foi realizado estudo transversal para determinar a taxa
de soroprevalência da infecção pelo VHE em 996 candidatos a doadores
de sangue. Todos os participantes responderam um questionário sobre
características sociodemográficas. A pesquisa de anticorpos específicos
IgG anti-VHE foi realizada por método de enzimaimunoensaio
(ELISA). Todas as amostras soropositivas para IgG anti-VHE e 237
amostras soronegativas para IgG anti-VHE foram submetidas também
à pesquisa de IgG anti-VHA por ELISA. Entre as 996 amostras de
soro analisadas, anticorpos IgG anti-VHE foram detectados em 23
amostras, resultando em uma soroprevalência de 2,3% (IC 95%: 1,5 -
3,5), semelhante aos resultados de estudos realizados em países
desenvolvidos. Não houve associação entre o índice de soropositividade
de IgG anti-VHE e as variáveis sociodemográficas (sexo, idade,
escolaridade, procedência, fonte de água e origem dos dejetos); também
não se detectou associação entre soropositividade para IgG anti-VHE
com soropositividade para IgG anti-VHA. Os resultados obtidos
sugerem que, embora tenha se observado uma baixa prevalência da
infecção pelo VHE na população analisada, verificou-se que existe
circulação do VHE no município de Londrina e que estudos posteriores
são necessários para definir a importância clínica e epidemiológica da
infecção pelo VHE nesse município bem como identificar outros
possíveis fatores de risco envolvidos na epidemiologia da infecção
pelo VHE.
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